Nano-medicine and Theranostics
The introduction of genes or drugs into cells has been used for a wide range of medical applications. We are studying the use of physical delivery of drug or reprogramming factors into the cells and tissue, as a safe and reliable method as well as exploring integrated diagnostic and therapeutic (theranostics) modalities/nanoparticles/agents, as a unique approach in nanomedicine.
Unit coordinatorTakuro NIIDOME WebsiteProfessor, Faculty of Advanced Science and Technology, Kumamoto UniversityJapan
Ick Chan KWON WebsitePresidential Scholar, Dana Faber Cancer Center, Harvard Medical School/ Principal Research Scientist, Biomedical Research Institute, Korea Institute of Science and Technology (KIST)USA/ Republic of Korea
Ruda LEE WebsiteAssociate Professor, International Research Organization for Advanced Science and Technology (IROAST), Kumamoto UniversityJapan
Keiichi MOTOYAMA WebsiteAssociate Professor, Graduate School of Pharmaceutical Sciences, Kumamoto UniversityJapan
Taishi HIGASHI WebsiteAssociate Professor, Priority Organization for Innovation and Excellence, Kumamoto UniversityJapan